KRAS/BRAF Analysis in Ovarian Low-Grade Serous Carcinoma Having Synchronous All Pathological Precursor Regions.

about

Low frequency of BRAF and KRAS mutations in Chinese patients with low-grade serous carcinoma of the ovary.KRAS mutation testing in borderline ovarian tumors and low-grade ovarian carcinomas with a rapid, fully integrated molecular diagnostic system.

P2860

Q47136918-03A7F8C2-9170-4E49-842D-6895F836923D Q47248242-D298AEC8-2F60-486A-8F79-7957BAB541D1

P2860

KRAS/BRAF Analysis in Ovarian Low-Grade Serous Carcinoma Having Synchronous All Pathological Precursor Regions.

Item

http://www.wikidata.org/entity/Q36939085

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

KRAS/BRAF Analysis in Ovarian ...... athological Precursor Regions.

@en

type

Item

label

KRAS/BRAF Analysis in Ovarian ...... athological Precursor Regions.

@en

prefLabel

KRAS/BRAF Analysis in Ovarian ...... athological Precursor Regions.

@en

P1476

KRAS/BRAF Analysis in Ovarian ...... athological Precursor Regions.

@en

P2093

Emi Sato

http://www.w3.org/2001/XMLSchema#string

Hiroshi Katagiri

http://www.w3.org/2001/XMLSchema#string

Hitomi Yamashita

http://www.w3.org/2001/XMLSchema#string

Kaori Sanuki

http://www.w3.org/2001/XMLSchema#string

Kentaro Nakayama

http://www.w3.org/2001/XMLSchema#string

Kohei Nakamura

http://www.w3.org/2001/XMLSchema#string

Kouji Iida

http://www.w3.org/2001/XMLSchema#string

Masako Ishikawa

http://www.w3.org/2001/XMLSchema#string

Noriyoshi Ishikawa

http://www.w3.org/2001/XMLSchema#string

Razia Sultana

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

KRAS (but not BRAF) mutations in ovarian serous borderline tumour are associated with recurrent low-grade serous carcinoma

Molecular genetic analysis of ovarian serous cystadenomas.

Diverse tumorigenic pathways in ovarian serous carcinoma.

Mutational landscape of mucinous ovarian carcinoma and its neoplastic precursors.

Molecular pathogenesis of ovarian borderline tumors: new insights and old challenges.

Low-grade serous carcinomas of the ovary contain very few point mutations

Mutational analysis of K-ras segregates ovarian serous carcinomas into two types: invasive MPSC (low-grade tumor) and conventional serous carcinoma (high-grade tumor).

Ovarian serous tumors of low malignant potential (borderline tumors): outcome-based study of 276 patients with long-term (> or =5-year) follow-up.

Noninvasive and invasive micropapillary (low-grade) serous carcinoma of the ovary: a clinicopathologic analysis of 135 cases.

P31

scholarly article

P356

10.3390/IJMS17050625

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-04-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27128903

http://www.w3.org/2001/XMLSchema#string

P932

4881451

http://www.w3.org/2001/XMLSchema#string

KRAS/BRAF Analysis in Ovarian Low-Grade Serous Carcinoma Having Synchronous All Pathological Precursor Regions.

about

P2860

P2860

KRAS/BRAF Analysis in Ovarian Low-Grade Serous Carcinoma Having Synchronous All Pathological Precursor Regions.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P407

P433

P478

P577

P698

P932